NCT00005872View on ClinicalTrials.gov

Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1999

Study Completion Date

April 30, 2004

Conditions
Lung Cancer
Interventions
DRUG

rubitecan

Trial Locations (1)

94568

SuperGen, Incorporated, Dublin

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY